• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.

作者信息

Klingenberg R, Zugck C, Becker R, Schellberg D, Heinze G, Kell R, Remppis A, Schoels W, Katus H A, Dengler T J

出版信息

Heart. 2006 Sep;92(9):1323-4. doi: 10.1136/hrt.2005.076117.

DOI:10.1136/hrt.2005.076117
PMID:16908708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861173/
Abstract
摘要

相似文献

1
Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.升高的B型利钠肽可预测缺血性心肌病患者的植入式心脏复律除颤器治疗。
Heart. 2006 Sep;92(9):1323-4. doi: 10.1136/hrt.2005.076117.
2
Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies.接受适当植入式心脏除颤器治疗的患者中N末端B型利钠肽原水平升高。
Heart Lung. 2009 Jan-Feb;38(1):10-6. doi: 10.1016/j.hrtlng.2007.12.005. Epub 2008 Sep 11.
3
B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators.B型利钠肽水平可预测植入式心脏复律除颤器患者的无事件生存期。
Eur J Heart Fail. 2007 Mar;9(3):272-9. doi: 10.1016/j.ejheart.2006.07.004. Epub 2006 Oct 5.
4
B-type natriuretic peptide: a role in selection and follow up of the implantable cardioverter-defibrillator patient?B型利钠肽：在植入式心脏复律除颤器患者的选择和随访中发挥作用？
Heart. 2006 Feb;92(2):147-8. doi: 10.1136/hrt.2005.070888.
5
Brain natriuretic peptide as a predictor of sudden cardiac death in patients with myocardial infarction.脑钠肽作为心肌梗死患者心源性猝死的预测指标。
J Am Coll Cardiol. 2004 Oct 6;44(7):1528-9; author reply 1529. doi: 10.1016/j.jacc.2004.07.006.
6
Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.N 端前脑钠肽与电生理研究在预测心肌梗死后植入式心律转复除颤器患者未来结局中的比较。
Am J Cardiol. 2007 Aug 15;100(4):635-9. doi: 10.1016/j.amjcard.2007.03.074. Epub 2007 Jun 26.
7
Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.血清心肌胶原代谢标志物紊乱：与心力衰竭患者心脏再同步除颤器治疗后恶性室性心律失常的关系。
Am Heart J. 2012 Oct;164(4):530-7. doi: 10.1016/j.ahj.2012.07.006.
8
Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.植入式心脏复律除颤器对晚期心力衰竭女性心脏性猝死一级预防的有效性：一项随机对照试验的荟萃分析。
Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.
9
Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.未接受过适当植入式心脏复律除颤器治疗的死亡：一项竞争风险研究。
Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.
10
Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.优化一级预防植入式心脏复律除颤器治疗的患者选择：收紧撒得太广的网。
Circulation. 2009 Sep 8;120(10):825-7. doi: 10.1161/CIRCULATIONAHA.109.891069. Epub 2009 Aug 24.

引用本文的文献

1
N-terminal pro-B-type natriuretic peptide for prediction of ventricular arrhythmias: Data from the SMASH study.N 末端 pro-B 型利钠肽预测室性心律失常：来自 SMASH 研究的数据。
Clin Cardiol. 2023 Aug;46(8):989-996. doi: 10.1002/clc.24074. Epub 2023 Jul 3.
2
Risk Stratification of Sudden Cardiac Death After Acute Myocardial Infarction.急性心肌梗死后心脏性猝死的风险分层
J Innov Card Rhythm Manag. 2018 Feb 15;9(2):3035-3049. doi: 10.19102/icrm.2018.090201. eCollection 2018 Feb.
3
Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death.经典和新型生物标志物作为室性心律失常和心源性猝死的潜在预测指标
J Clin Med. 2020 Feb 20;9(2):578. doi: 10.3390/jcm9020578.
4
Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?在接受个体化优化治疗的稳定型慢性心力衰竭患者中，连续测量 NT-proBNP 是否有额外获益？
Clin Res Cardiol. 2011 Dec;100(12):1059-67. doi: 10.1007/s00392-011-0340-1. Epub 2011 Jul 16.
5
Biomarkers in heart failure: a clinical review.心力衰竭的生物标志物：临床综述。
Heart Fail Rev. 2010 Jul;15(4):251-73. doi: 10.1007/s10741-008-9123-9. Epub 2008 Dec 3.
6
Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events.非缺血性心肌病患者B型利钠肽水平升高预示心律失常事件的发生。
Clin Res Cardiol. 2008 May;97(5):306-9. doi: 10.1007/s00392-007-0629-2. Epub 2008 Jan 14.

本文引用的文献

1
Cost-effectiveness of implantable cardioverter-defibrillators.植入式心脏复律除颤器的成本效益
N Engl J Med. 2005 Oct 6;353(14):1471-80. doi: 10.1056/NEJMsa051989.
2
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.B型利钠肽可预测慢性心力衰竭患者的猝死。
Circulation. 2002 May 21;105(20):2392-7. doi: 10.1161/01.cir.0000016642.15031.34.
3
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.心力衰竭优化治疗后血浆脑钠肽和白细胞介素-6水平升高是充血性心力衰竭患者发病和死亡的独立危险因素。
J Am Coll Cardiol. 2000 Nov 1;36(5):1587-93. doi: 10.1016/s0735-1097(00)00912-8.
4
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.心力衰竭猝死患者尸检时的急性冠状动脉病变：赖诺普利治疗与生存评估（ATLAS）试验结果
Circulation. 2000 Aug 8;102(6):611-6. doi: 10.1161/01.cir.102.6.611.
5
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.从近乎致命的室性心律失常中复苏的患者，抗心律失常药物治疗与植入式除颤器的比较。
N Engl J Med. 1997 Nov 27;337(22):1576-83. doi: 10.1056/NEJM199711273372202.